EC
UPB

EntryPoint Capital’s Upstream Bio Inc UPB Stock Holding History

EntryPoint Capital’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$662K Buy
+73,568
New +$1.32M 0.19% 157

Other funds holding UPB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EntryPoint Capital's UPB Position: Q1 2026 in Review

EntryPoint Capital opened a new position in Upstream Bio Inc (UPB) in Q1 2026: 73,568 shares worth $662K. The stake represents 0.19% of the portfolio and ranks #157 among its holdings.

140 funds tracked by Wall St. Rank hold UPB as of Q1 2026.

  • EntryPoint Capital held 73,568 shares of Upstream Bio Inc worth $662K as of Q1 2026.
  • Upstream Bio Inc was a new EntryPoint Capital position in Q1 2026.
  • Upstream Bio Inc made up 0.19% of EntryPoint Capital's portfolio in Q1 2026, its #157 holding.
  • 140 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q1 2026.

Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.